323 related articles for article (PubMed ID: 31630993)
21. Racial and ethnic variation in multigene panel testing in a cohort of BRCA1/2-negative individuals who had genetic testing in a large urban comprehensive cancer center.
Tatineni S; Tarockoff M; Abdallah N; Purrington KS; Assad H; Reagle R; Petrucelli N; Simon MS
Cancer Med; 2022 Mar; 11(6):1465-1473. PubMed ID: 35040284
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.
Nicolosi P; Ledet E; Yang S; Michalski S; Freschi B; O'Leary E; Esplin ED; Nussbaum RL; Sartor O
JAMA Oncol; 2019 Apr; 5(4):523-528. PubMed ID: 30730552
[TBL] [Abstract][Full Text] [Related]
23. Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center.
Chapman-Davis E; Zhou ZN; Fields JC; Frey MK; Jordan B; Sapra KJ; Chatterjee-Paer S; Carlson AD; Holcomb KM
J Gen Intern Med; 2021 Jan; 36(1):35-42. PubMed ID: 32720237
[TBL] [Abstract][Full Text] [Related]
24. Bringing Prostate Cancer Germline Genetics into Clinical Practice.
Das S; Salami SS; Spratt DE; Kaffenberger SD; Jacobs MF; Morgan TM
J Urol; 2019 Aug; 202(2):223-230. PubMed ID: 30730411
[TBL] [Abstract][Full Text] [Related]
25. Disparities in precision medicine-Examining germline genetic counseling and testing patterns among men with prostate cancer.
Borno HT; Odisho AY; Gunn CM; Pankowska M; Rider JR
Urol Oncol; 2021 Apr; 39(4):233.e9-233.e14. PubMed ID: 33158741
[TBL] [Abstract][Full Text] [Related]
26. Clinical Germline Testing Results of Men With Prostate Cancer: Patient-Level Factors and Implications of NCCN Guideline Expansion.
Greenberg SE; Hunt TC; Ambrose JP; Lowrance WT; Dechet CB; O'Neil BB; Tward JD
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250421
[TBL] [Abstract][Full Text] [Related]
27. Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing.
Truong H; Sheikh R; Kotecha R; Kemel Y; Reisz PA; Lenis AT; Mehta NN; Khurram A; Joseph V; Mandelker D; Latham A; Ceyhan-Birsoy O; Ladanyi M; Shah NJ; Walsh MF; Voss MH; Lee CH; Russo P; Coleman JA; Hakimi AA; Feldman DR; Stadler ZK; Robson ME; Motzer RJ; Offit K; Patil S; Carlo MI
Eur Urol Oncol; 2021 Dec; 4(6):993-1000. PubMed ID: 34654685
[TBL] [Abstract][Full Text] [Related]
28. Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings.
Seifert BA; O'Daniel JM; Amin K; Marchuk DS; Patel NM; Parker JS; Hoyle AP; Mose LE; Marron A; Hayward MC; Bizon C; Wilhelmsen KC; Evans JP; Earp HS; Sharpless NE; Hayes DN; Berg JS
Clin Cancer Res; 2016 Aug; 22(16):4087-4094. PubMed ID: 27083775
[TBL] [Abstract][Full Text] [Related]
29. Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and Melanoma.
AlDubayan SH; Conway JR; Camp SY; Witkowski L; Kofman E; Reardon B; Han S; Moore N; Elmarakeby H; Salari K; Choudhry H; Al-Rubaish AM; Al-Sulaiman AA; Al-Ali AK; Taylor-Weiner A; Van Allen EM
JAMA; 2020 Nov; 324(19):1957-1969. PubMed ID: 33201204
[TBL] [Abstract][Full Text] [Related]
30. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.
Hamel N; Kotar K; Foulkes WD
BMC Med Genet; 2003 Aug; 4():7. PubMed ID: 12911837
[TBL] [Abstract][Full Text] [Related]
31. Germline Mutations in African American Men With Prostate Cancer: Incidence, Implications and Diagnostic Disparities.
Bree KK; Hensley PJ; Pettaway CA
Urology; 2022 May; 163():148-155. PubMed ID: 34453957
[TBL] [Abstract][Full Text] [Related]
32. A multicenter study of clinical impact of variant of uncertain significance reclassification in breast, ovarian and colorectal cancer susceptibility genes.
Makhnoon S; Levin B; Ensinger M; Mattie K; Volk RJ; Zhao Z; Mendoza T; Shete S; Samiian L; Grana G; Grainger A; Arun B; Shirts BH; Peterson SK
Cancer Med; 2023 Feb; 12(3):2875-2884. PubMed ID: 36426404
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of genetic alterations in hereditary cancer susceptibility genes in the Ashkenazi Jewish women community of Mexico.
Díaz-Velásquez CE; Gitler R; Antoniano A; Kershenovich Sefchovich R; De La Cruz-Montoya AH; Martínez-Gregorio H; Rojas-Jiménez EA; Cortez Cardoso Penha R; Terrazas LI; Wegman-Ostrosky T; Levi-Lahad E; Zabaleta J; Perdomo S; Vaca-Paniagua F
Front Genet; 2023; 14():1094260. PubMed ID: 36845387
[No Abstract] [Full Text] [Related]
34. Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines.
So MK; Jeong TD; Lim W; Moon BI; Paik NS; Kim SC; Huh J
Breast Cancer; 2019 Jul; 26(4):510-519. PubMed ID: 30725392
[TBL] [Abstract][Full Text] [Related]
35. Pathogenic Germline Mutational Landscape in Patients With Renal Cell Carcinoma and Associated Clinicopathologic Features.
Nguyen CB; Knaus C; Li J; Accardo ML; Koeppe E; Vaishampayan UN; Alva AS; Else T
JCO Precis Oncol; 2023 Sep; 7():e2300168. PubMed ID: 38127826
[TBL] [Abstract][Full Text] [Related]
36. Novel Germline Mutations in a Cohort of Men with Familial Prostate Cancer.
Mondschein R; Bolton D; Clouston D; Dowty J; Kavanagh L; Murphy D; Scott P; Taylor RA; Thorne H
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892882
[No Abstract] [Full Text] [Related]
37. Hereditary Cancer Gene Variants in Hispanic Men With a Personal or Family History of Prostate Cancer.
Ramamurthy C; Stutz EW; Goros M; Gelfond J; Johnson-Pais TL; Thompson IM; Leach RJ; Liss MA
Clin Genitourin Cancer; 2022 Jun; 20(3):237-243. PubMed ID: 35260348
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of universal germline testing for men with prostate cancer in an Australian tertiary center.
Crumbaker M; Wong J; Joshua AM; Spigelman AD
Asia Pac J Clin Oncol; 2019 Aug; 15(4):257-261. PubMed ID: 31012270
[TBL] [Abstract][Full Text] [Related]
39. Clinical Management of Patients at Risk for Hereditary Breast Cancer with Variants of Uncertain Significance in the Era of Multigene Panel Testing.
Chang J; Seng S; Yoo J; Equivel P; Lum SS
Ann Surg Oncol; 2019 Oct; 26(10):3389-3396. PubMed ID: 31342386
[TBL] [Abstract][Full Text] [Related]
40. Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants.
Liu YL; Maio A; Kemel Y; Salo-Mullen EE; Sheehan M; Tejada PR; Trottier M; Arnold AG; Fleischut MH; Latham A; Carlo MI; Murciano-Goroff YR; Walsh MF; Mandelker D; Mehta N; Bandlamudi C; Arora K; Zehir A; Berger MF; Solit DB; Aghajanian C; Diaz LA; Robson ME; Brown CL; Offit K; Hamilton JG; Stadler ZK
Cancer; 2022 Nov; 128(21):3870-3879. PubMed ID: 36041233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]